Pierre Noël

Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness

Amy D. Klion, Pierre Noël, Cem Akin et al. · Blood · 2003 · 390 citations · Full text

Medicine, Internal Medicine, Pathology +15

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

Javier Bolaños‐Meade, Ran Reshef, Raphael Fraser et al. · The Lancet Haematology · 2019 · 281 citations

Medicine, Immunology, Pharmacotherapy +16

Phase I Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With B-Cell Malignancies

Robert J. Kreitman, David Squires, Maryalice Stetler‐Stevenson et al. · Journal of Clinical Oncology · 2005 · 257 citations · Full text

Medicine, Hematology, Pharmacology +12

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome

Amy D. Klion, Jamie Robyn, Cem Akin et al. · Blood · 2003 · 242 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxis

Cem Akin, Linda M. Scott, Can Naci Kocabaş et al. · Blood · 2007 · 239 citations · Full text

Life Sciences, Immunology, Pathology +15